Cargando…
Rosiglitazone reduces diabetes angiopathy by inhibiting mitochondrial dysfunction dependent on regulating HSP22 expression
The effects of rosiglitazone (RSG) in patients with type 2 diabetes mellitus (T2DM) remain controversial. Here, we first used network pharmacology to identify the common targets of RSG in the treatment of diabetes angiopathy (DA). Enrichment analysis found that the common genes were involved in the...
Autores principales: | Yu, Lingling, Chen, Shengsong, Liang, Qian, Huang, Chahua, Zhang, Weifang, Hu, Longlong, Yu, Yun, Liu, Liang, Cheng, Xiaoshu, Bao, Huihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031002/ https://www.ncbi.nlm.nih.gov/pubmed/36968091 http://dx.doi.org/10.1016/j.isci.2023.106194 |
Ejemplares similares
-
HSP22 suppresses diabetes-induced endothelial injury by inhibiting mitochondrial reactive oxygen species formation
por: Yu, Lingling, et al.
Publicado: (2019) -
The role of lncRNA CASC2 on prognosis of malignant tumors: a
meta-analysis and bioinformatics
por: Yu, Lingling, et al.
Publicado: (2018) -
Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia/reperfusion injury by transferring miR-24
por: Minghua, Wen, et al.
Publicado: (2018) -
Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction
por: Baselet, Bjorn, et al.
Publicado: (2020) -
The relationship between the atherogenic index of plasma and arterial stiffness in essential hypertensive patients from China: a cross-sectional study
por: Yin, Juan, et al.
Publicado: (2021)